Quarterly report pursuant to Section 13 or 15(d)

7. SEGMENTS (Tables)

v3.3.0.814
7. SEGMENTS (Tables)
 9 Months Ended
Sep. 30, 2015
Segment Reporting [Abstract]  
SEGMENTS

 

    Plasma                    
Three Months Ended   Collection   Research and              
September 30, 2015   Centers   Development     Corporate   Consolidated  
                         
Revenues   $ 1,821,229     $ -     $ 31,184     $ 1,852,413  
Cost of product revenue     1,112,782       -       -       1,112,782  
Gross profit     708,447       -       31,184       739,631  
Loss from operations     (505,711 )     (2,111,505 )     (2,046,982 )     (4,664,198 )
Other expense     -       -       (438,226 )     (438,226 )
Net loss     (505,711 )     (2,111,505 )     (2,485,208 )     (5,102,424 )
Property and equipment,                                
net     2,387,682       -       130,956       2,518,638  
Depreciation and                                
amortization expense     105,192       -       12,738       117,930  
                                 
    Plasma                          
Three Months Ended   Collection   Research and                  
September 30, 2014   Centers   Development     Corporate   Consolidated  
                                 
Revenues   $ 1,347,041     $ -     $ 18,889     $ 1,365,930  
Cost of product revenue     867,681       -       -       867,681  
Gross profit     479,360       -       18,889       498,249  
Loss from operations     (539,022 )     (1,482,929 )     (1,016,331 )     (3,038,282 )
Other expense     -       -       (346,407 )     (346,407 )
Net loss     (539,022 )     (1,482,929 )     (1,362,738 )     (3,384,689 )
Property and equipment,                                
net     2,227,587       -       153,613       2,381,200  
Depreciation and                                
amortization expense     41,135       1,110       11,954       54,199  

 

    Plasma                    
Nine Months Ended   Collection   Research and              
September 30, 2015   Centers   Development     Corporate   Consolidated  
                         
Revenues   $ 4,596,490     $ -     $ 68,962     $ 4,665,452  
Cost of product revenue     2,808,726       -       -       2,808,726  
Gross profit     1,787,764       -       68,962       1,856,726  
Loss from operations     (1,571,366 )     (5,019,138 )     (4,792,636 )     (11,383,140 )
Other income (expense)     -       -       (2,004,137 )     (2,004,137 )
Net loss     (1,571,366 )     (5,019,138 )     (6,796,773 )     (13,387,277 )
Property and equipment,                                
net     2,387,682       -       130,956       2,518,638  
Depreciation and                                
amortization expense     315,209       -       37,420       352,629  
                                 
    Plasma                          
Nine Months Ended   Collection   Research and                  
September 30, 2014   Centers   Development     Corporate   Consolidated  
                                 
Revenues   $ 4,370,141     $ -     $ 56,667     $ 4,426,808  
Cost of product revenue     2,785,526       -       -       2,785,526  
Gross profit     1,584,615       -       56,667       1,641,282  
Loss from operations     (1,057,085 )     (7,597,295 )     (3,655,208 )     (12,309,588 )
Other income (expense)     262       -       (940,480 )     (940,218 )
Net loss     (1,056,823 )     (7,597,295 )     (4,595,688 )     (13,249,806 )
Property and equipment,                                
net     2,227,587       -       153,613       2,381,200  
Depreciation and                                
amortization expense     113,292       2,729       35,041       151,062